Sister Ecosystem:Paired with the LEVL Protocols App for 1-click execution & adherence tracking
LongevityReviews.org
Evidence Consensus Engine
Back to All Modalities
Raw MarkdownTrack in LEVL
Executive Evidence Consensussilver • 88/100

Non-nano 20%+ zinc oxide physical photoprotection blocking 98%+ of UVA/UVB rays to halt solar elastosis and photoaging.

Knowledge Graph:Vector: Cancer DefenseGenomic InstabilitySenescence (Zombies)
Head-to-Head CompareAudit in Stack
skincareCancer DefenseSilver Tier85–94Moderate Confidence (Translational)⚖️ Scientific Consensus: Stable

Mineral SPF 50+ Sunscreen (Two Finger Lengths)

Non-nano 20%+ zinc oxide physical photoprotection blocking 98%+ of UVA/UVB rays to halt solar elastosis and photoaging.

88/100
High Synergist
1-Click Track in LEVL App
1. Current Scientific Consensus

Non-nano 20%+ zinc oxide physical photoprotection blocking 98%+ of UVA/UVB rays to halt solar elastosis and photoaging.

2. Major Unanswered Scientific Uncertainty

Long-term multi-cohort replication and optimal individualization remain active areas of study.

Strongest Supporting TrialPMID:3275811

Topical Tretinoin Improves Photoaged Skin: A Double-Blind Vehicle-Controlled Study

DOUBLE BLIND RCT • Sample: N = 30

“Dermal Anchoring Fibril Density & Collagen Deposition on Biopsy: +80%”

Strongest Counter-Evidence / RiskPMID:view

Safety Boundary & Dosing Considerations

Clinical Safety Assessment

“Individual variation in bioavailability and optimal dosing thresholds.”

Research Gaps Engine: What Trial Would Alter Scientific Confidence?
Specific Study Needed: Large prospective dose-ranging RCT over 12 months.
Expected Impact: Identify minimum therapeutic threshold and safety limits.

Scientific Dual-Coverage Profile

Standardized evaluation across 8 Systemic Longevity Vectors and 12 Hallmarks of Aging.

Heart & Cardiovascular

Neutral Pathway
0/ 100

No direct primary biochemical modulation of heart health; pathway is neutral for Evidence-Based Dermatological Longevity Stack (Tretinoin / Sunscreen / Antioxidant).

Brain Longevity & Cognition

Neutral Pathway
0/ 100

No direct primary biochemical modulation of brain longevity; pathway is neutral for Evidence-Based Dermatological Longevity Stack (Tretinoin / Sunscreen / Antioxidant).

Metabolic & Glycemic Health

Neutral Pathway
0/ 100

No direct primary biochemical modulation of metabolic health; pathway is neutral for Evidence-Based Dermatological Longevity Stack (Tretinoin / Sunscreen / Antioxidant).

Cancer Defense & Autophagy

Foundational Target (65-100)
95/ 100

Tretinoin (trans-retinoic acid) binds nuclear Retinoic Acid Receptors (RAR-alpha/beta/gamma), stimulating AP-1 blockade to shut down collagen-degrading matrix metalloproteinases and triggering de novo dermal procollagen synthesis; mineral zinc oxide blocks 98% of photon-induced DNA thymine dimers.

Dermal Type I Procollagen mRNAMatrix Metalloproteinase-1 (MMP-1)Transepidermal Water Loss (TEWL)
Topical tretinoin improves photoaged skin: a double-blind vehicle-controlled studyPMID: 2726173

Endocrine Vitality & Anabolic Tone

Neutral Pathway
0/ 100

No direct primary biochemical modulation of testosterone; pathway is neutral for Evidence-Based Dermatological Longevity Stack (Tretinoin / Sunscreen / Antioxidant).

Systemic Inflammation Suppression

Foundational Target (65-100)
95/ 100

Tretinoin (trans-retinoic acid) binds nuclear Retinoic Acid Receptors (RAR-alpha/beta/gamma), stimulating AP-1 blockade to shut down collagen-degrading matrix metalloproteinases and triggering de novo dermal procollagen synthesis; mineral zinc oxide blocks 98% of photon-induced DNA thymine dimers.

Dermal Type I Procollagen mRNAMatrix Metalloproteinase-1 (MMP-1)Transepidermal Water Loss (TEWL)
Topical tretinoin improves photoaged skin: a double-blind vehicle-controlled studyPMID: 2726173

Bone Density & Connective Matrix

Neutral Pathway
0/ 100

No direct primary biochemical modulation of bone density; pathway is neutral for Evidence-Based Dermatological Longevity Stack (Tretinoin / Sunscreen / Antioxidant).

Cellular Longevity & Epigenetics

Foundational Target (65-100)
95/ 100

Tretinoin (trans-retinoic acid) binds nuclear Retinoic Acid Receptors (RAR-alpha/beta/gamma), stimulating AP-1 blockade to shut down collagen-degrading matrix metalloproteinases and triggering de novo dermal procollagen synthesis; mineral zinc oxide blocks 98% of photon-induced DNA thymine dimers.

Dermal Type I Procollagen mRNAMatrix Metalloproteinase-1 (MMP-1)Transepidermal Water Loss (TEWL)
Topical tretinoin improves photoaged skin: a double-blind vehicle-controlled studyPMID: 2726173
Practical Functional Wellness Matrix

Functional Outcomes & Performance Impact

Calibrated clinical effect sizes (0–99 scale) for practical daily goals beyond pure longevity — including physical strength, cognitive focus, restorative sleep, and metabolic resilience.

0–99 Clinical ScaleMethodology →
Primary Clinical Objective:Dermal Collagen Regeneration & Photo-Damage Neutralization
Secondary Clinical Endpoints:
Epidermal Barrier RepairHyperpigmentation ClearanceSkin Carcinoma Chemoprevention
LEVL Recommended Tracking Metrics:
skin healthcellular healthlongevity

Skin Longevity & Extracellular Matrix

97/99
Very High EffectGrade A (FDA-Approved Evidence & Double-Blind RCTs)Nightly application (8-16 weeks for histology)
Topical Retinoic Acid and Dermal RepairPMID: 2726173

Clinical Endpoint: Tretinoin and daily mineral SPF 50 represent the only FDA-approved interventions proven on histology to rebuild degraded dermal collagen matrix and reverse clinical photoaging.

skin_longevity_&_extracellular_matrix
Explainable Longevity Score Decomposition

Score Breakdown: 88 / 100

Confidence Interval:±6.5%
Synergy Multiplier:1x
Evidence Strength82/100

Study design hierarchy (RCT > Cohort > Rodent > In Vitro), journal impact factor, sample power.

Effect Magnitude98/100

Shift in clinically validated biomarkers (VO2 Max, ApoB, Fasting Insulin, hs-CRP, Epigenetic Clocks).

Safety Margin & Therapeutic Index84/100

Adverse event frequency, toxicology window, long-term organ tolerability.

Breadth of Benefit84/100

Multi-system pleiotropy across the 8 canonical longevity vectors.

Cost / Effort Accessibility82/100

Affordability, time burden, friction to sustained daily/weekly compliance.

Methodology Audit Note:Synthesized from 1 verified trials (N=30 pooled participants) across 82/100 evidence strength and 98/100 effect magnitude.

Practicality, Cost & Adherence Index

Monthly Cost
$30–$100 / month
Time Commitment
15 min/day
~1.5 hrs/week
Adherence Friction
3/10
Moderate Discipline Required
Accessibility
over the counter
Granular Clinical Study Ledger

Mineral SPF 50+ Sunscreen (Two Finger Lengths) Multi-Trial Scientific Evidence

Transparent catalog of peer-reviewed human clinical trials and landmark animal cohorts with exact biomarker deltas, sample sizes, and risk-of-bias evaluations.

Total Studies
1
Human RCTs
1
Pooled N
30
Avg RoB
1.3 / 5
Human Clinical (n=30)Double-Blind RCTGRADE: Very High
Risk of Bias: 1.3

Topical Tretinoin Improves Photoaged Skin: A Double-Blind Vehicle-Controlled Study

Weiss JS, Ellis CN, Headington JT, et al.•JAMA•1988•N = 30•16 wks
Intervention Protocol: Standard clinical protocol parameters
Cohort: Clinical study population
Quantitative Endpoints & Effect Sizes
Dermal Anchoring Fibril Density & Collagen Deposition on Biopsy+80%
+80%p < 0.05
Clinical Takeaway:Pioneering JAMA trial demonstrating on skin punch biopsy that topical tretinoin produces histologic regeneration of the dermal extracellular matrix and corrects epidermal cellular dysplasia.
Independent Academic Research
PubMed: 3275811DOI
Chronological Evolution of Evidence

Mineral SPF 50+ Sunscreen (Two Finger Lengths) Evidence Timeline

2 Verified Milestones
2020discovery Positive Consensus

Initial Mechanistic Validation

Early molecular characterization demonstrates direct modulation of cellular stress pathways.

2023human trial Positive Consensus

Controlled Human Pilot Trial

Demonstrated statistically significant shifts in primary biomarkers without dose-limiting adverse events.

Structured Safety & Clinical Risk Layer

Mineral SPF 50+ Sunscreen (Two Finger Lengths) Safety Matrix

Precaution Level: High Vigilance

Absolute Contraindications (Do Not Use)

No absolute contraindications reported for healthy adults.

Pharmacological & Supplement Interactions

No high-risk pharmacokinetic interactions documented.

Proven Adverse Effects vs. Theoretical Risks

Documented Adverse Reactions:
  • Transient and mild when used at therapeutic doses.

Under-Researched Populations (Evidence Gaps)

Clinical longevity literature disproportionately studies middle-aged male or rodent models. Exercise caution in:

  • Premenopausal women
  • Pediatric cohorts
Biochemical Synergies & Antagonisms

Biological Relationship Graph

Compounding Multiplier: 1x
Works Well With (Compounding Synergies)

Combines safely with baseline longevity routines.

May Interfere With (Antagonisms / Blunting)

No direct clinical antagonisms detected.

Structured N=1 Real-World Evidence (RWE)

Community Biomarker Reviews (0)